Dr. Jordan Spence Zuckerman, M.D. Dermatology - Procedural Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2383 Bell Blvd, Upper Level, Bayside, NY 11360 Phone: 718-423-0200 Fax: 718-423-3134 |
Eric J Fryer, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 21008 Northern Blvd, Bayside, NY 11361 Phone: 718-224-8200 Fax: 718-819-0244 |
Lillian R Graf, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 21418 24th Ave, Bayside, NY 11360 Phone: 718-428-6000 Fax: 718-423-5102 |
News Archive
Slimmer Silhouette is excited to announce the Perfect 10 Challenge, an engaging health and life-makeover challenge for 2010 that encourages women in leadership positions at charities and non-profit organizations nationwide to champion their cause by taking better care of themselves.
People who had higher pre-pandemic levels of depression or anxiety have been more severely affected by disruption to jobs and healthcare during the pandemic, according to a new study co-led by UCL researchers.
Variations in heart rate patterns provide information on how the nervous system functions in adults and children. Obstetricians have long considered heart rate patterns to be important indicators of fetal well-being during the prenatal period as well as in labor and delivery.
Konica Minolta Medical Imaging announced today the new SIGMA II CS-7s Computed Radiography (CR) system, designed to deliver enterprise level imaging to community hospitals, clinics and private practices. By utilizing the same Control Station as the Konica Minolta AeroDR wireless flat panel detector, economic value is assured with an upgrade path from CR to DR.
Ocugen, Inc. and the University of Colorado today announced exclusive license agreements that allow for Ocugen to continue developing two drug candidates for the treatment for ophthalmology indications, and that one of the assets, OCU100, recombinant lens epithelium derived growth factor 1-326 (LEDGF1-326), received orphan-drug status from the U.S. Food and Drug Administration for treatment of retinitis pigmentosa (RP), a rare eye disease.
› Verified 3 days ago